4 years ago

Influence of Metabolic Syndrome and Race on the Relationship between Intensive Blood Pressure Control and Cardiovascular Outcomes in the SPRINT Cohort

Uzma Rani, William E. Haley, Kathleen Dungan, Kwame Osei, Alan Wiggers, Jeff Whittle, Leonardo Tamariz, Jan Basile, Jackson T. Wright, Nancy R. Kressin, Kyaw Soe, Timothy E. Craven
Aims To determine whether baseline metabolic syndrome (MetS) modifies the effect of intensive blood pressure control on cardiovascular (CV) outcomes, and whether effects varied by race/ethnicity. Materials and Methods We performed post-hoc analyses among Non-Hispanic Black (NHB), Non-Hispanic White (NHW), and Hispanic participants with and without MetS in the Systolic Blood Pressure Intervention Trial (SPRINT) randomized to a systolic blood pressure (SBP) target of less than 120 mm Hg (intensive group, N = 4544) or one less than 140 mm Hg (standard group, N = 4553). Median follow-up was 3.26 years. The primary outcome was the composite of the first occurrence of myocardial infarction (MI), stroke, heart failure, non-MI acute coronary syndrome, or (CV) death. Results Overall, 3521/9097 (38.7%) of subjects met criteria for MetS at baseline. Baseline characteristics were similar between SBP groups within each MetS subgroup except BMI was slightly higher in the Standard arm of the MetS subgroup (33.3+/−5.6 vs. 33.0+/−5.3, p < 0.01) but similar across treatment arms in the non-MetS subgroup. The hazard ratio (HR) for the primary outcome was similarly reduced in subjects with or without baseline MetS (0.75 [95% CI 0.57, 0.96] and 0.71 [0.57, 0.87] respectively, adjusted p-value for treatment by subgroup interaction = 0.98). Similarly, there was no evidence of treatment by MetS subgroup interaction for all-cause mortality (adjusted interaction p value = 0.98). The findings were also similar across race/ethnic subgroups. Conclusions In this analysis the CV benefit of intensive SBP control did not differ among subjects by baseline MetS status, regardless of race/ethnicity.

Publisher URL: http://onlinelibrary.wiley.com/resolve/doi

DOI: 10.1111/dom.13127

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.